New tool combining evolution and AI predicts prostate cancer recurrence more than a decade ahead 11 Jul 2024 Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis. Find out more Show/Hide
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy 04 Apr 2023 Two key proteins linked to cell division can reliably predict disease recurrence in prostate cancer after radiotherapy treatment, according to new research. Find out more Show/Hide
Shorter radiotherapy courses for prostate cancer are well tolerated long-term by patients 19 Sep 2021 A shorter course of radiotherapy, administered through fewer, higher intensity doses, is as well tolerated over five years as longer treatment courses for treating prostate cancer, long-term results of a clinical trial show. Find out more Show/Hide
Avoiding penile bulb with radiotherapy could save men with prostate cancer from harmful side-effects 28 Nov 2016